Related Experiment Video
Updated: May 6, 2026
09:47
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
9.6K
Starch-based "smart" nanomicelles: Potential delivery systems for doxorubicin.
Parteek Prasher1, Mousmee Sharma2
1Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, India.
Drug Development Research
|August 29, 2024
Summary
Starch-based nanomicelles offer improved delivery of Doxorubicin (DOX), overcoming its limitations like toxicity and short half-life. These smart systems enhance drug targeting and bioavailability for better cancer therapy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Delivery Systems
Background:
- Vesicular nanosystems enhance drug pharmacokinetics and bioavailability.
- Doxorubicin (DOX) chemotherapy faces challenges including nonspecific interactions, dose-limiting toxicity (myelosuppression), and a short half-life, limiting clinical efficacy.
Purpose of the Study:
- To evaluate starch-based nanomicelles as an advanced delivery system for Doxorubicin (DOX).
- To address the limitations of conventional Doxorubicin delivery through smart nanomicelle design.
Main Methods:
- Development of "smart" nanomicelles with stimuli-responsive linkages for targeted drug release.
- Incorporation of stealth properties to evade immunogenic responses.
- Co-loading of magnetic nanoparticles for theranostic applications.
Main Results:
- Starch-based nanomicelles demonstrate potential for improved Doxorubicin (DOX) delivery.
- Stimuli-responsive linkages enable targeted drug deployment in the tumor microenvironment, reducing toxicity.
- Stealth properties mitigate protein interactions and immunogenic responses.
Conclusions:
- Starch-based nanomicelles represent a promising platform for overcoming Doxorubicin (DOX) delivery challenges.
- These systems offer enhanced targeting, reduced toxicity, and potential for theranostics.
- The developed nanomicelles improve the overall effectiveness of Doxorubicin chemotherapy.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167